Total Payments
$449,880
2024 Payments
$82,075
Companies
36
Transactions
709
Medicare Patients
12,472
Medicare Billing
$1.9M
Payment Breakdown by Category
Other$400,478 (89.0%)
Food & Beverage$27,825 (6.2%)
Travel$17,332 (3.9%)
Consulting$4,050 (0.9%)
Education$195.63 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $400,478 | 160 | 89.0% |
| Food and Beverage | $27,825 | 499 | 6.2% |
| Travel and Lodging | $17,332 | 39 | 3.9% |
| Consulting Fee | $4,050 | 3 | 0.9% |
| Education | $195.63 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $135,807 | 71 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $109,578 | 182 | $0 (2024) |
| Amgen Inc. | $65,454 | 78 | $0 (2024) |
| Amarin Pharma Inc. | $35,619 | 45 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $35,148 | 41 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25,261 | 48 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $21,060 | 22 | $0 (2018) |
| Lilly USA, LLC | $12,095 | 16 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,543 | 23 | $0 (2020) |
| Boston Scientific Corporation | $1,705 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82,075 | 49 | Novo Nordisk Inc ($71,615) |
| 2023 | $42,646 | 43 | Novo Nordisk Inc ($24,248) |
| 2022 | $62,743 | 58 | Novo Nordisk Inc ($39,508) |
| 2021 | $29,975 | 46 | Janssen Pharmaceuticals, Inc ($15,861) |
| 2020 | $26,543 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,467) |
| 2019 | $64,661 | 116 | Janssen Pharmaceuticals, Inc ($21,284) |
| 2018 | $54,354 | 192 | Janssen Pharmaceuticals, Inc ($21,528) |
| 2017 | $86,883 | 167 | Novartis Pharmaceuticals Corporation ($30,771) |
All Payment Transactions
709 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,487.50 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,487.50 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $105.90 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,456.25 | General |
| 11/12/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $985.17 | General |
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.01 | General |
| 11/06/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,037.50 | General |
| 11/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/24/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,456.25 | General |
| 10/24/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $782.66 | General |
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.85 | General |
| 10/17/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,487.50 | General |
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $109.27 | General |
| 10/09/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,456.25 | General |
| 10/09/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $708.09 | General |
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $118.42 | General |
| 10/08/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $167.09 | General |
| Category: Implant Cardio Defib - ICDs | ||||||
| 09/25/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,006.25 | General |
| 09/25/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $816.16 | General |
| 09/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $117.71 | General |
| 09/24/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,487.50 | General |
| 09/24/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $763.51 | General |
| 09/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,093 | 5,467 | $3.2M | $457,882 |
| 2022 | 17 | 3,167 | 5,814 | $3.4M | $513,307 |
| 2021 | 15 | 3,153 | 5,649 | $3.0M | $513,099 |
| 2020 | 18 | 3,059 | 5,184 | $2.9M | $455,806 |
Total Patients
12,472
Total Services
22,114
Medicare Billing
$1.9M
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 647 | 1,671 | $1.2M | $181,939 | 15.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 533 | 546 | $818,454 | $91,247 | 11.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 100 | 100 | $214,100 | $41,588 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 235 | 289 | $142,766 | $21,488 | 15.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 117 | 227 | $181,600 | $21,363 | 11.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 676 | 1,657 | $230,323 | $19,707 | 8.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 100 | 101 | $146,955 | $17,703 | 12.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 140 | 140 | $29,400 | $10,070 | 34.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 62 | 238 | $43,792 | $9,646 | 22.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 152 | 161 | $94,829 | $9,328 | 9.8% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 32 | 35 | $49,630 | $8,545 | 17.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 26 | 26 | $39,962 | $5,735 | 14.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 144 | 144 | $15,408 | $5,181 | 33.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $15,336 | $5,082 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $26,593 | $4,219 | 15.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $8,490 | $2,253 | 26.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 20 | 20 | $17,540 | $1,240 | 7.1% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 19 | 22 | $4,862 | $783.64 | 16.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $1,819 | $611.66 | 33.6% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $1,265 | $152.13 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 643 | 1,708 | $1.2M | $194,791 | 16.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 491 | 511 | $765,989 | $89,427 | 11.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 144 | 146 | $310,847 | $64,236 | 20.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 178 | 357 | $285,600 | $35,380 | 12.4% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 62 | 63 | $56,700 | $21,499 | 37.9% |
About Dr. Evan Schwarzwald, D.O
Dr. Evan Schwarzwald, D.O is a Cardiovascular Disease healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164414330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evan Schwarzwald, D.O has received a total of $449,880 in payments from pharmaceutical and medical device companies, with $82,075 received in 2024. These payments were reported across 709 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($400,478).
As a Medicare-enrolled provider, Schwarzwald has provided services to 12,472 Medicare beneficiaries, totaling 22,114 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Great Neck, NY
- Active Since 08/16/2005
- Last Updated 07/28/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164414330
Products in Payments
- XARELTO (Drug) $109,570
- Repatha (Biological) $65,273
- Ozempic (Drug) $37,514
- JARDIANCE (Drug) $36,989
- Vascepa (Drug) $35,619
- ENTRESTO (Drug) $35,148
- Livalo (Drug) $21,060
- Wegovy (Drug) $17,981
- Rybelsus (Drug) $14,539
- Reveal LINQ (Device) $1,380
- CardioInsight (Device) $1,054
- FARXIGA (Drug) $1,022
- WATCHMAN (Device) $724.42
- TOUJEO (Drug) $329.60
- Pogo Automatic Blood Glucose Monitoring System (Device) $289.43
- Barostim Neo System (Device) $280.30
- Claria MRI (Device) $271.41
- SOLIQUA (Drug) $249.88
- WATCHMAN Access System (Device) $244.09
- BYDUREON (Drug) $224.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Great Neck
Dr. Steven Goldberg, M.d, M.D
Cardiovascular Disease — Payments: $78,555
Cardiovascular Disease $78,555
Dr. David Stern, M.d, M.D
Cardiovascular Disease — Payments: $25,959
Cardiovascular Disease $25,959
Dr. Lauren Boglioli, Md Facc Facp Fccp, MD FACC FACP FCCP
Cardiovascular Disease — Payments: $15,130
Cardiovascular Disease $15,130
Dr. Joel Goldberg, Md, MD
Cardiovascular Disease — Payments: $8,960
Cardiovascular Disease $8,960
Navid Ahmed, M.d, M.D
Cardiovascular Disease — Payments: $8,200
Cardiovascular Disease $8,200
Dr. William Blau, Md, MD
Cardiovascular Disease — Payments: $7,393
Cardiovascular Disease $7,393